Actavis temporarily closes Digitek recall plant over manufacturing problems
Drugmaker Actavis has reached an agreement with U.S. health authorities to temporarily close three New Jersey plants in order to resolve violations of Food and Drug Admininstration “Good Manufacturing Practices” that occurred there. The company agreed to close two manufacturing plants and a third packaging plant until it could show that it was in compliance [...]
FDA orders raid on digoxin manufacturing plants
Federal marshals raided three manufacturing plants run by Caraco Pharmaceutical Laboratories this week at the request of the Food and Drug Administration. All three plants were shut down and more than $20 million in generic drugs were seized after the FDA found continued violations of federal health and safety requirements. Caraco manufactures several types of [...]
Digitek lawsuit filed on behalf of 97 former patients
A lawsuit on behalf of 97 former Digitek patients was filed this week in an Illinois court. The Digitek lawsuit filed on behalf of these patients alleges that they were injured after taking tablets of the heart medication that were improperly manufactured at twice their normal strength. Digitek is also sold generically as digoxin. Drugmaker [...]